SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
1 Year Est. Return
+73.47%
AUM
$121M
AUM Growth
-$4.02M
(-3.2%)
Holding
84
Top Buys
| 1 | +$1.62M | |
| 2 | +$1.35M | |
| 3 | +$1.3M | |
| 4 |
Bristol-Myers Squibb
BMY
|
+$1.23M |
| 5 |
Medtronic
MDT
|
+$1.06M |
Top Sells
| 1 | +$1.4M | |
| 2 | +$1.38M | |
| 3 | +$1.02M | |
| 4 |
CTNM
Contineum Therapeutics
CTNM
|
+$982K |
| 5 |
Eli Lilly
LLY
|
+$935K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVMN
1
Evommune Inc
EVMN
$711M
| $13.5M | 11.22% |
589,005
|
|
||
|
CTNM
2
Contineum Therapeutics
CTNM
$467M
| $9.5M | 7.87% |
727,587
-73,200
|
|
||
|
SI
3
Shoulder Innovations Inc
SI
$287M
| $6.25M | 5.18% |
430,407
-62,028
|
|
||
|
4
Eli Lilly
LLY
$962B
| $5.84M | 4.84% |
6,354
-922
|
|
||
5
Johnson & Johnson
JNJ
$537B
| $4.45M | 3.69% |
18,218
-2,082
|
|
||
6
Gilead Sciences
GILD
$160B
| $4.13M | 3.42% |
27,490
+9,605
|
|
||
7
UnitedHealth
UNH
$342B
| $4.05M | 3.35% |
14,957
+1,362
|
|
||
8
Amgen
AMGN
$183B
| $3.51M | 2.91% |
9,210
-3,860
|
|
||
9
Vertex Pharmaceuticals
VRTX
$109B
| $3.46M | 2.86% |
7,007
-998
|
|
||
10
Insmed
INSM
$22.5B
| $3.38M | 2.8% |
19,668
+8,486
|
|
||
11
argenx
ARGX
$50.6B
| $2.74M | 2.27% |
3,564
+670
|
|
||
12
AbbVie
ABBV
$384B
| $2.65M | 2.2% |
12,200
-4,600
|
|
||
13
Abbott
ABT
$152B
| $2.63M | 2.18% |
25,578
+2,080
|
|
||
14
Merck
MRK
$283B
| $2.58M | 2.14% |
21,480
+80
|
|
||
15
Regeneron Pharmaceuticals
REGN
$64.9B
| $2.48M | 2.06% |
2,919
-796
|
|
||
16
Intuitive Surgical
ISRG
$144B
| $2.42M | 2% |
5,250
+400
|
|
||
17
Boston Scientific
BSX
$70.9B
| $2.18M | 1.81% |
34,780
+7,154
|
|
||
18
BioNTech
BNTX
$22.4B
| $2.05M | 1.69% |
22,164
+4,946
|
|
||
19
Stryker
SYK
$113B
| $1.93M | 1.6% |
5,874
-676
|
|
||
20
Danaher
DHR
$126B
| $1.82M | 1.51% |
9,597
-978
|
|
||
21
Thermo Fisher Scientific
TMO
$176B
| $1.72M | 1.43% |
3,508
-392
|
|
||
22
DexCom
DXCM
$28.1B
| $1.46M | 1.21% |
23,231
-5,469
|
|
||
23
IQVIA
IQV
$30.4B
| $1.42M | 1.17% |
+8,307
|
|
||
24
Summit Therapeutics
SMMT
$11.7B
| $1.4M | 1.16% |
69,615
-10,010
|
|
||
25
Edwards Lifesciences
EW
$49.5B
| $1.39M | 1.15% |
17,338
+88
|
|